CA2293324A1 - 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine maleate - Google Patents

5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine maleate Download PDF

Info

Publication number
CA2293324A1
CA2293324A1 CA002293324A CA2293324A CA2293324A1 CA 2293324 A1 CA2293324 A1 CA 2293324A1 CA 002293324 A CA002293324 A CA 002293324A CA 2293324 A CA2293324 A CA 2293324A CA 2293324 A1 CA2293324 A1 CA 2293324A1
Authority
CA
Canada
Prior art keywords
acid addition
addition salt
ethyl
methyl
maleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002293324A
Other languages
English (en)
French (fr)
Inventor
Ole Nielsen
Michael Bech Sommer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2293324A1 publication Critical patent/CA2293324A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002293324A 1997-07-01 1998-07-01 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine maleate Abandoned CA2293324A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01
DK0781/97 1997-07-01
PCT/DK1998/000294 WO1999001448A1 (en) 1997-07-01 1998-07-01 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate

Publications (1)

Publication Number Publication Date
CA2293324A1 true CA2293324A1 (en) 1999-01-14

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002293324A Abandoned CA2293324A1 (en) 1997-07-01 1998-07-01 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine maleate

Country Status (25)

Country Link
EP (1) EP0994869A1 (tr)
JP (1) JP2002507215A (tr)
KR (1) KR20010014297A (tr)
CN (1) CN1261361A (tr)
AR (1) AR013096A1 (tr)
AU (1) AU735751B2 (tr)
BG (1) BG103933A (tr)
BR (1) BR9810331A (tr)
CA (1) CA2293324A1 (tr)
CO (1) CO4940483A1 (tr)
EA (1) EA200000081A1 (tr)
HU (1) HUP0002876A2 (tr)
IL (1) IL133093A0 (tr)
IS (1) IS5278A (tr)
JO (1) JO2031B1 (tr)
MA (1) MA25138A1 (tr)
NO (1) NO996580L (tr)
PE (1) PE116099A1 (tr)
PL (1) PL337184A1 (tr)
SK (1) SK187399A3 (tr)
TN (1) TNSN98120A1 (tr)
TR (1) TR199903283T2 (tr)
UY (2) UY25069A1 (tr)
WO (1) WO1999001448A1 (tr)
ZA (1) ZA985498B (tr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
TR199800801T2 (tr) * 1995-11-06 1998-08-21 H. Lund-Beck A/S Travmatik beyin yaralanmalarinin tedavisi.

Also Published As

Publication number Publication date
PE116099A1 (es) 1999-11-23
JP2002507215A (ja) 2002-03-05
CO4940483A1 (es) 2000-07-24
BG103933A (en) 2000-07-31
IS5278A (is) 1999-11-30
AR013096A1 (es) 2000-12-13
SK187399A3 (en) 2000-06-12
NO996580D0 (no) 1999-12-30
HUP0002876A2 (hu) 2001-06-28
CN1261361A (zh) 2000-07-26
TR199903283T2 (tr) 2000-06-21
AU735751B2 (en) 2001-07-12
AU8102098A (en) 1999-01-25
NO996580L (no) 1999-12-30
JO2031B1 (en) 1999-05-15
BR9810331A (pt) 2000-09-05
MA25138A1 (fr) 2001-04-02
PL337184A1 (en) 2000-08-14
EP0994869A1 (en) 2000-04-26
UY25069A1 (es) 1998-12-21
WO1999001448A1 (en) 1999-01-14
UY25177A1 (es) 2000-12-29
EA200000081A1 (ru) 2000-08-28
ZA985498B (en) 1999-01-20
IL133093A0 (en) 2001-03-19
KR20010014297A (ko) 2001-02-26
TNSN98120A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
DE69524114T2 (de) Naphthyridinonderivate
JPH09500875A (ja) タキキニン拮抗薬としての4−フェニル−4−フェニルプロピル(エチル)−ピペリジン
DE69111816T2 (de) Indolederivate und ihre verwendung als serotonin-antagoniste.
WO2002010172A1 (fr) Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
EP0610793A1 (en) Tetracyclic morpholine derivatives and their use or analgesics
TW201102385A (en) Substituted triazolopyridines and analogs thereof
JPH054983A (ja) イソキノリノン誘導体、その製造方法およびその誘導体を有効成分として含有する5−ht3 レセプター拮抗剤
US4891376A (en) 1-((2-Pyrimidinyl)aminoalkyl)piperidines, their preparation and their application in therapy
JPH06510537A (ja) 5−ht4レセプター・アンタゴニスト
JP2022547617A (ja) Il-17aモジュレーターおよびその使用
JP7301209B2 (ja) 2,4,6-トリフルオロ-n-[6-(1-メチル-ピペリジン-4-カルボニル)-ピリジン-2-イル]-ベンズアミドヘミコハク酸塩の大規模調製のためのプロセスおよび中間体、ならびに2,4,6-トリフルオロ-n-[6-(1-メチル-ピペリジン-4-カルボニル)-ピリジン-2-イル]-ベンズアミド酢酸塩の調製
TW202128642A (zh) 用於疾病治療之雙白胺酸拉鍊(dlk)激酶的雙環[1.1.1]戊烷抑制劑
MXPA04010313A (es) Polimorfo del acido 4- [2-[4 -[1(2- etoxietil) -1h- bencimidazol -2-il]-1 -piperidinil] etil]- alfa, alfa- dimetil -bencenoacetico.
WO1991001979A1 (en) New aminopiperazine derivatives
JPH05506249A (ja) ビスーベンゾシクロヘプタピペリジリデン、ピペリジンおよびピペラジン化合物、組成物および使用法
WO1989009767A1 (en) Carbamoyl-2-pyrrolidinone compounds
CA2164296C (en) Heterocyclic chemistry
CN101243074A (zh) 杂环化合物
AU735751B2 (en) 5-(2-ethyl-2H-tetrazol-5-Y1)-1-methyl-1,2,3,6-tetrahydro pyridine maleate
EA009460B1 (ru) Триазольные соединения, полезные в терапии
CN102770431A (zh) [4[4-(5-氨基甲基-2-氟-苯基)-哌啶-1-基]-(1h-吡咯并吡啶-基)-甲酮及其合成
DE69515498T2 (de) Naphthyridinderivate
MXPA03005884A (es) Hemimaleato de amlodipina.
US7335380B2 (en) Amlodipine free base
EP0523013B1 (en) Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued